Prazosin Alcohol Dependence IVR Study

Summary

This double-blind placebo controlled pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduced alcohol consumption and alcohol craving in alcohol dependent individuals without Post Traumatic Stress Disorder (PTSD). The intervention period is six weeks.

Timeline

Start

2005-09

Primary completion

2007-10

Completion

2007-10

Drugs

Indications